Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Chronic Mountain Sickness
NCT00424970Phase 4Completed
- Sponsor
- ARPE
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in Chronic Mountain Sickness (CMS), sponsored by ARPE. Started Jan 2007; status: completed.
02
Drugs
acetazolamide
03
Conditions
Chronic Mountain Sickness (CMS)
Beyond the preview
Go deeper on NCT00424970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424970.